In an exclusive interview with the Journal of Medicine and Public Health (MSP), Dr. Angel Chenya, a neurologist, spoke about the need for vaccination against COVID-19 in patients with multiple sclerosis, and explained that so far, the indulgence has not developed. The implications of vaccination, which is very interesting for the multidisciplinary team of doctors who treat patients with this medical condition.
Angel Chenia, Neurologist.
Marcella Moreno WelshiesLatin Agency for News Medicine and Public Health
According to the observed data and records, it has been shown that this group of patients is not more susceptible to the disease than the general population, and therefore, the behavior in front of the vaccine will be the same as that seen in others.
“We at the Multiple Sclerosis Foundation are conducting an analysis of patients who have had the disease, who have positive results on the molecular test and the antibody test, and we have seen that in these patients, the deaths are in fact,” Dr. Chenya explained.
Likewise, when analyzing the record of this group of patients who have already been vaccinated, and who are being followed up for side effects, a group of different entities is sought to assess the prevalence and number of cases of patients with SARS. -CoV-2 has been found to have very low mortality and morbidity, in both Puerto Rico and the United States.
The specialist stated that compared to the different types of vaccines, as one of them is Pfizer and Modern, it can be proven that they are different vaccines in the mechanisms of action, where the genetic material of the virus actually enters the viruses. It produces destruction and halts disease progression.
For its part, Johnson & Johnson requires a single dose and its component depends on changing the virus from which the genetic material is obtained and that enters the viral cell to develop immunity.
The specialist pointed out that “in patients who have been vaccinated, we can say that side effects are almost non-existent, and those who may have sensitivity in the injection area and a syndrome similar to a mild viral infection that usually lasts between 24 hours or less are removed.” .
Patients with other comorbidities
“It is important to be vaccinated, and for the MS patient to be vaccinated, but this is voluntary. We do not force anyone, we understand that herd immunity is important, after we have 70% of the vaccinated population we will be able to control this epidemic,” .
Although there is no evidence about when to receive the vaccine, Dr. Chenya stressed that patients can do so at any time, whether they are on injectable or oral treatments, as there is no evidence of change or relapses related to the vaccination process. vaccination.
The effectiveness of the vaccine
The effectiveness of the vaccine is measured by immunity against this new virus, in patients who are given by injection or orally, and can be vaccinated at any time, on the other hand, in more aggressive treatments such as infections where there is a change or deficiency in immunity that can The system is under the guidance of a specialist.
“There is a group of treatments that reduce the number of cells, and in this case we have to look for an opportunity. What we recommend to the patient is to be vaccinated, perhaps before starting the treatment, and there we can delay the start of treatment … the chance to get the vaccination before starting the treatment, we try to do that after Three or four months after the last infusion, ”the doctor told MSP.
For other patients, when their cell count rises to a level close to 800, it would be a good time to introduce the vaccination
“In the case of our clinic, we have prepared a vaccination protocol where we would like to look at the patient’s immunity status in five different treatments and we will measure immunity before vaccination and we will see how the immunologist said that the response to COVID is a month after the second dose in the case of Moderna and Pfizer and in the case of Johnson & Johnson after the first dose.
Each neurologist or specialist in multiple sclerosis creates his own guide taking into account the mechanism of action of each treatment, so it is appropriate to have recommendations from your family doctor to take into account the health condition of each patient the herd community prefers to be arrived in a short time.